Experimental data suggest a biphasic role: in early MI Gal-3 may cause cytoprotective and anti-inflammatory effects, whereas persistent elevation in the later phase contributes to chronic inflammation, fibrosis, and adverse ventricular remodelling [12,13]. This evidence concerns the gene LGALS3 and myocardial infarction.